Home › SSRETAIL › Filing
🔔 Get instant alerts when SSRETAIL files quarterly results on BSE Start free trial →
SS Retail Limited (SSRETAIL)

Investor Presentation

Filed: 15 Nov 2026, 14:36 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 & H1 FY27 - Revenue grew 87% y-y to Rs 940 Cr in Q2; Rs 1729 Cr in H1, +73% y-y - EBITDA margin steady at 5.6% in Q2 and H1; EBITDA nearly doubled y-y - PAT margin improved to 3.0% in Q2 and H1; PAT rose 160% in Q2, 102% in H1 - Store count increased to 574 with 70% in Tier II/III+ towns; 750-store target by FY28 - Focus on profitable expansion, operating leverage, and scaling higher-margin adjacencies - Strong balance sheet with improving ROE (31% FY26) and efficient working capital - MD Siddharth Shah: targeting to double revenue from FY26 base over next 2 years
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SSRETAIL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SSRETAIL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on SS Retail Limited

Important. The summary above is generated automatically from SS Retail Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.